Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Phase 1 Z944 Dosing Complete; Focus Turns To Synavive

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/3/2026

1. SPY
2. PLTR
3. CVX
4. AMZN
5. ITGR
6. KKR
7. MSTR
8. SPCX
9. ARES
10. SNAP

Go back to Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Phase 1 Z944 Dosing Complete; Focus Turns To Synavive
ZALICUS (NASDAQ: ZLCS) Delayed: 1.18 --0 (-0%)
Previous Close $1.18    52 Week High $1.74 
Open $17.62    52 Week Low $0.86 
Day High $1.18    P/E N/A 
Day Low $1.18    EPS $-1.70 
Volume 577,304